Navigation Links
Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
Date:12/8/2008

y Grade 2 and 3 non-hematologic adverse events decreased considerably between months one to three and months four to six(2).

The second study, conducted by researchers at MD Anderson Cancer Center, is an ongoing Phase II clinical trial investigating the efficacy and safety of Tasigna as initial therapy for patients with CML-CP (chronic phase). The current analysis, which includes data from 48 patients, shows that nearly all evaluable patients (96%) achieved CCyR. By six and 12 months, 45% and 52% of patients achieved MMR, respectively. Adverse reactions were manageable with temporary treatment interruptions or dose reductions(1). Notably, there was no marked incidence of severe fluid retention or effusions, side effects commonly observed with other drugs of this class.

About Tasigna

Tasigna (nilotinib) capsules is indicated for the treatment of chronic phase and accelerated phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adult patients resistant or intolerant to prior therapy that included imatinib. Tasigna has been approved in more than 50 countries. The effectiveness of Tasigna is based on hematologic and cytogenetic response rates. There are no controlled trials demonstrating a clinical benefit, such as improvement in disease-related symptoms or increased survival. Please see Important Safety Information, including Warning below.

Tasigna important safety information

    WARNING: QT PROLONGATION AND SUDDEN DEATHS

    TASIGNA prolongs the QT interval. Sudden deaths have been reported in
    patients receiving nilotinib. TASIGNA should not be used in patients with
    hypokalemia, hypomagnesemia, or long QT syndrome. Hypokalemia or
    hypomagnesemia must be corrected prior to TASIGNA administration and
    should be periodically monitored. Drugs known to prolong the QT interval
    and strong CYP3
'/>"/>
SOURCE Novartis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
8. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
9. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
10. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
11. Video: Sanford Healths Journey to Cure Type 1 Diabetes Receives Major Boost
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014  A substantial share of pharmacy ... which therapies are included in formularies—say patient support ... a new Manhattan Research study, Taking the ... finds that P&T committee members in hospitals, managed ... have set a high bar for these programs, ...
(Date:7/31/2014)... , July 31, 2014 Catylix, ... Aspira Scientific ( Milpitas, California ) ... to develop and commercialize new fluorination products and ... molecules has benefited from the use of substituents ... combine lipophilicity with polarity to improve binding and ...
(Date:7/31/2014)... Ariz. , July 31, 2014 For ... public can watch the implantation of the SynCardia temporary ... paper and matching video posted on the Journal of ... video and read the paper on the SynCardia Total ... The 16-minute video accompanies "Implantation of the SynCardia Total ...
Breaking Medicine Technology:Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3
... Md. , May 6 The U.S. Food and Drug Administration ... , , , ... , , ... (estradiol valerate) and a progestin (dienogest), and is the first four-phasic oral contraceptive ...
... An innovative catheter-based procedure is providing relief to patients who suffer ... severely leaky heart valve, but who are too sick for open-chest surgery, ... and Interventions (SCAI) 33rd Annual Scientific Sessions. , ... Data from the Endovascular Valve Edge-to-Edge REpair STudy ...
Cached Medicine Technology:FDA Approves New Combination Product Oral Contraceptive 2MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 2MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 3MitraClip Safely Relieves Symptoms in Patients With No Surgical Options 4
(Date:7/31/2014)... Dayton, Ohio (PRWEB) July 31, 2014 ... members of its faculty, Anthony Le Donne and Peter ... 1. Also new to United is a Director ... on August 1. , Anthony Le Donne, Assistant ... University, United Kingdom. He teaches New Testament, Second Temple ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Cosmetic Town ... best Plastic Surgeons to consumers considering cosmetic treatments. ... their peers whose goal is to educate prospective patients ... are selected through a validated referral system that helps ... the best in their respective fields. , Cosmetic ...
(Date:7/31/2014)... NY (PRWEB) July 31, 2014 The ... to open the airway and provide an easier breathing ... The end results are that people can breathe easier ... device is entirely adjustable so that it can meet ... effectiveness for snorers is often shared by actual customer ...
(Date:7/31/2014)... July 31, 2014 Ce-Classes.com has ... to help healthcare agencies to pass inspections and ... agencies meet their accreditation and state licensing ... training. , Healthcare administrators can monitor employee ... of the mouse. Courses can be developed based ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Andrie, Inc. V. ... , The Michigan Supreme Court has made the determination that ... use tax when the taxpayer was unable to prove during ... purchases. The Court reversed the Court of Appeals decision on ... the use tax exemption for purchases from Michigan sellers. The ...
Breaking Medicine News(10 mins):Health News:Growing Seminary Welcomes New Faculty 2Health News:The New Doctors’ Directory, Cosmetic Town Does the Research for Consumers of Plastic Surgeries 2Health News:New Dental Device Reviews to Stop Snoring by VitalSleep 2Health News:Company Helps Healthcare Agencies to Pass Inspections and Audits 2Health News:Company Helps Healthcare Agencies to Pass Inspections and Audits 3Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 2Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 3
... MELVILLE, N.Y., March 3 Gentiva Health,Services, Inc. ... of,comprehensive home health services, announced today that it ... interest in Home Health Care,Affiliates, Inc. and certain ... in cash, subject to post-closing adjustments., The ...
... 3 New information about food,and diet appears every ... friend,s personal endorsement of a trendy diet, news reports,about ... and how do you,separate the truth from the fiction ... Nutrition Month(R), the American Dietetic Association,urges consumers to look ...
... AIDS Vaccine Initiative (IAVI) today announced the first award ... will identify and advance potential breakthrough technologies and apply ... project will apply an exciting new technology, a simulated ... which has the potential to predict human immune responses ...
... 3 Therap Services, a service,bureau providing ... working with people with developmental disabilities, will,host ... 15, 2008 in Sioux Falls, South,Dakota. The ... day,program directors, state caseworkers, nurses, supervisors, house ...
... Researchers at the University of Southern California (USC) have ... vaccines by turning off the suppression function of regulatory ... is an antigen presentation attenuator, and its inhibition overcomes ... Medicine on March 2, 2008. , Under normal circumstances, ...
... especially need to readjust to cope with loss of hour,s sleep ... Planning ahead and following a few simple steps can help you ... one hour on March 9, says the American Academy of Sleep ... the return to Daylight Saving Time (DST): , Begin to ...
Cached Medicine News:Health News:Gentiva(R) Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi 2Health News:Gentiva(R) Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi 3Health News:During National Nutrition Month and Beyond, Find the Facts on Nutrition by Focusing on the Science 2Health News:IAVI and VaxDesign partner to develop a clinical trial in a test tube for AIDS vaccines 2Health News:Therap Services to Host Regional Conference in South Dakota 2Health News:USC researchers discover novel way to develop tumor vaccines 2
... Traveler provides the ultimate flexibility for performing ... in the home, a patient room or ... utilize the same powerful Sleepscan VISION analysis ... studies take full advantage of many powerful ...
... in Digital EEG ,The company that ... presents the latest addition to the ... This innovative system incorporates the latest ... information management to offer you unprecedented ...
"Ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Complies with international standards of electrophysiology....
The field of application of the SL 120 Slit Lamp extends from the anterior ocular segment and the vitreous right back to the fundus. It is the ideal configuration for observation, measurement, diagno...
Medicine Products: